Coronary In-Stent Restenosis
Gennaro Giustino(Cardiovascular Institute of the South), Samin K. Sharma(Mount Sinai Health System), Antonio Colombo(Humanitas University), Gregg W. Stone(Cardiovascular Institute of the South), Anton Camaj(Columbia University Irving Medical Center), Annapoorna Kini(Mount Sinai Medical Center), Keisuke Yasumura(Cardiovascular Institute of the South), Roxana Mehran(Mount Sinai Hospital)
Cited by 397
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k